Antibody Drug Therapy

Conventional anticancer therapeutics often suffer from lack of specificity, resulting in toxicities to normal healthy tissues and poor therapeutic index. Antibody-drug conjugates (ADCs) constitute a therapeutic modality in which a cytotoxic agent is chemically linked to an antibody (Ab) that recognizes a tumor-associated antigen. The basic strategy underlying ADC technology is to combine the target selectivity of mAbs with the potency of cytotoxic agents, such as certain natural products and synthetic molecules, with the goal of generating therapeutic drugs that are highly efficacious but also safe. The ADC platform currently includes a growing repertoire of cytotoxic payloads, linker technologies and conjugation methods. Two ADCs have recently received FDA approval and more than 30 are in clinical development. This meeting aims to highlight advances in ADC research, clinical development and regulatory perspectives.

Topics will range from early phase research focused on development of novel linker-payload and conjugation chemistries to clinical concepts and development of biomarkers and patient selection strategies.

  • Challenges and New Opportunities with Antibody and Protein Drugs
  • Novel Antibody and Biologic Drug Targets
  • Innovative Antibody drugs in Clinical Trail and Development
  • Antibody-drug Conjugate (ADC) Discovery and Development
  • Bispecific and Multispecific antibody discovery and development

Related Conference of Antibody Drug Therapy

June 29-July 01, 2017

8th European Immunology Conference

Madrid, Spain
July 03-05, 2017

9th Asia-Pacific Global Summit on Healthcare & Immunology

Kuala Lumpur, Malaysia
July 12-13, 2017

3rd World Conference on Parasitology & Pathogenesis

Chicago, Illinois, USA
September 01-02, 2017

4th International Conference on Parasitology

Prague, Czech Republic
September 11-12, 2017

7th World Congress on Immunology

Amsterdam, Netherlands
November 2-3, 2017

9th World Congress and Expo on Immunology

Atlanta, Georgia, USA
November 02-03, 2017

9th World Congress on Immunity, Inflammation and Immunotherapies

Atlanta, Georgia, USA
November 06-07, 2017

2nd International Conference on Autoimmunity

Frankfurt, Germany
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress & B2B

Las Vegas, Nevada, USA
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE
April 16-17, 2018

EuroSciCon Conference on StemCell

Amsterdam, Netherlands
July 05-07, 2018

EuroSciCon Conference on Immunology

Vienna, Austria

Antibody Drug Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in